Fornatly et al. demonstrated that CD4+ T cells in GBM patients exhibit immunosenescence, marked by a significant increase in CD4+CD28-CD57+ T cells, a phenotype associated with T cell replicative senescence [36]. This evidence concerns the gene CD4 and glioblastoma.